Active Ingredient: LINAGLIPTIN
Proprietary Name: LINAGLIPTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A208448
Product Number: 001
Approval Date: Mar 30, 2023
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information